Bayesian analysis from phase III trials were underused and poorly reported: a systematic review.
Fiche publication
Date publication
avril 2020
Journal
Journal of clinical epidemiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MEYER Nicolas
Tous les auteurs :
Ferreira D, Vivot A, Diemunsch P, Meyer N
Lien Pubmed
Résumé
We assessed the reporting of replicability items with the BayesWatch guidelines and crucial items of Bayesian analyses with the ROBUST guidelines in reports of phase III trials.
Mots clés
Bayes, RCT, phase III, replicability
Référence
J Clin Epidemiol. 2020 Apr 4;: